Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6727)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 7, 2021 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cherri S, Noventa S, Zaniboni A. Pancreatic adenocarcinoma: Beyond first line, where are we? World J Gastroenterol 2021; 27(17): 1847-1863 [PMID: 34007126 DOI: 10.3748/wjg.v27.i17.1847] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i17/1847.htm |
| Number | Citing Articles |
| 1 |
Alain Couvineau, Pascal Nicole, Valérie Gratio, Thierry Voisin. The Orexin receptors: Structural and anti-tumoral properties. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.931970
|
| 2 |
Anabela Barros, Catarina Pulido, Manuela Machado, Maria Brito, Nuno Couto, Olga Sousa, Sónia Melo, Hélder Mansinho. Treatment optimization of locally advanced and metastatic pancreatic cancer (Review). International Journal of Oncology 2021; 59(6) doi: 10.3892/ijo.2021.5290
|
| 3 |
Se-Il Go, Sang-Cheol Lee, Woo Kyun Bae, Dae Young Zang, Hyun Woo Lee, Joung Soon Jang, Jun Ho Ji, Jung Hoon Kim, Sanggon Park, Sun Jin Sym, Yaewon Yang, So Yeon Jeon, In Gyu Hwang, Sung Yong Oh, Jung Hun Kang. Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). European Journal of Cancer 2021; 157: 21 doi: 10.1016/j.ejca.2021.08.002
|
| 4 |
Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora, Sara Lonardi, Marina Macchini, Mariacristina Di Marco, Guido Giordano, Enrico Vasile, Mario Scartozzi, Silvia Bozzarelli, Silvia Noventa, Maria Grazia Rodriquenz, Anna Maria Militello, Ilario Giovanni Rapposelli, Ingrid Garajova, Stefania De Lorenzo, Barbara Merelli, Alessandro Bittoni, Lisa Salvatore, Letizia Procaccio, Chiara Paratore, Andrea Spallanzani, Umberto Peretti, Monica Niger, Elisa Giommoni, Ilaria Bernardini, Emiliano Tamburini, Katia Bernardino, Laura Forti, Maria Maddalena Valente, Stefano Cascinu, Michele Milella, Michele Reni. Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). British Journal of Cancer 2023; 128(5): 877 doi: 10.1038/s41416-022-02086-w
|
| 5 |
Couvineau Alain, Nicole Pascal, Gratio Valérie, Voisin Thierry. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target. Molecules 2021; 26(16): 4849 doi: 10.3390/molecules26164849
|
| 6 |
Özgen Ahmet YILDIRIM, Erkan ERDUR. Pancreatic cancer treatment after FOLFIRINOX: prognostic importance of chemotherapy dose intensity and albumin/globulin ratio in second line. Journal of Health Sciences and Medicine 2022; 5(1): 156 doi: 10.32322/jhsm.1011658
|